EE227 Medical Costs in Patients with Pulmonary Arterial Hypertension (PAH) on Oral Triple Therapy including Selexipag in the United States (US): A retrospective Claims-Based Study
Abstract
Authors
Carly Worden Yuen Tsang Louise Yu Ambika Satija Marjolaine Gauthier-Loiselle